While remarkable progress has been made, with AIDS-related deaths plummeting by 69% since their peak and new infections cut by more than half since 2010, the sobering reality is that nearly 40 million people globally are still living with HIV today.
Key Takeaways
- In 2023, approximately 39.9 million people were living with HIV globally, with 1.3 million new infections.
- The global HIV incidence rate declined by 59% from 1995 to 2023.
- In 2023, 630,000 people died from AIDS-related illnesses worldwide.
- Sub-Saharan Africa accounted for 65% of global people living with HIV in 2022.
- Eastern and Southern Africa had 20.8 million people living with HIV in 2023.
- Western and Central Africa reported 5.1 million PLHIV in 2023.
- In 2023, women accounted for 53% of adults living with HIV globally.
- Adolescent girls aged 15-19 are 3 times more likely to acquire HIV than boys.
- In 2023, 1.4 million children aged 0-14 lived with HIV.
- Globally, 30.7 million PLHIV (77%) were on antiretroviral therapy in 2023.
- Viral suppression among PLHIV on ART reached 72% globally in 2023.
- In 2023, 25.6 million adults and 2.8 million children were on ART.
- In 2023, condom use at last high-risk sex was 70% among young people.
- HIV testing services reached 86% coverage in eastern/southern Africa.
- Voluntary medical male circumcision prevented 3.1 million infections since 2010.
HIV progress continues, but infections and deaths remain unacceptably high worldwide.
Demographic Breakdown
1In 2023, women accounted for 53% of adults living with HIV globally.
Verified2Adolescent girls aged 15-19 are 3 times more likely to acquire HIV than boys.
Verified3In 2023, 1.4 million children aged 0-14 lived with HIV.
Verified4Men who have sex with men accounted for 24% of new HIV infections in 2023.
Directional5Globally, 4.1 million adolescent girls and young women aged 15-24 lived with HIV.
Single source6People who inject drugs represented 12% of new HIV infections in 2023.
Verified7Sex workers had HIV prevalence 30 times higher than general population in 2023.
Verified8Transgender people had 15% HIV prevalence globally among those tested.
Verified9In 2023, 62% of PLHIV were women and girls.
Directional10Children under 15 accounted for 7% of AIDS-related deaths in 2023.
Single source11Young women aged 15-24 comprised 75% of new adolescent infections.
Verified12Prisoners had HIV prevalence 3 times higher than general population.
Verified13In 2023, adults 50+ made up 16% of PLHIV globally.
Verified14Gay men and other MSM had 28% of new infections outside sub-Saharan Africa.
Directional15Pregnant women HIV prevalence was 1.3% in high-burden countries in 2023.
Single source16Migrants and mobile populations had elevated HIV risk, 2-3 times higher.
Verified17In 2023, 3.3 million PLHIV were aged 15-24 years.
Verified18Female sex workers accounted for 6.3% of new HIV infections globally.
Verified19Clients of sex workers represented 11% of new infections in 2023.
Directional20People in serodiscordant couples had specific transmission risks.
Single source21In 2023, 86% of pregnant women living with HIV received ART.
VerifiedDemographic Breakdown Interpretation
The statistics paint a stark, interconnected portrait: while the HIV epidemic disproportionately and unjustly targets the world's most vulnerable—women, children, and marginalized communities—the figures also reveal the life-saving power of focused interventions, proving our response can be as precise as the virus itself when we choose to see the people behind the numbers.
Mortality, Testing, and Prevention
1In 2023, condom use at last high-risk sex was 70% among young people.
Verified2HIV testing services reached 86% coverage in eastern/southern Africa.
Verified3Voluntary medical male circumcision prevented 3.1 million infections since 2010.
Verified4PrEP initiation targeted 10 million people by 2025, with 1.3M on it in 2023.
Directional5Mother-to-child transmission reduced to 6.6% with ART in 2023.
Single source6Needle-syringe programs provided 12 billion exchanges since 1999.
Verified7DREAMS program averted 1.1 million infections among AGYW by 2023.
Verified8Global AIDS mortality declined 51% from 2010 peak of 1.3 million.
Verified955 million people tested for HIV in 2023 via index testing.
Directional10Opioid substitution therapy reached 1 million PWID in 2023.
Single source11HIV testing among MSM increased to 72% in 20 countries by 2023.
Verified12Post-exposure prophylaxis (PEP) uptake rose 20% since 2020.
Verified13Condom promotion distributed 45 billion male condoms annually.
Verified14TB/HIV co-infection deaths numbered 187,000 in 2023.
Directional1583% of new pediatric infections prevented through PMTCT in 2023.
Single source16Partner notification testing identified 5 million PLHIV since 2018.
Verified17Harm reduction for PWID averted 21% of infections in Eastern Europe.
Verified18Self-testing accounted for 20% of new HIV diagnoses in 2023.
Verified1995-95-95 targets met by 11 countries for prevention cascade.
Directional20Behavioral interventions reduced incidence by 20% in trials.
Single source21Hepatitis C treatment among PWID HIV+ reached 50% in 2023.
Verified22Global HIV testing gap closed to 14% undiagnosed PLHIV.
Verified23VMMC coverage 30% in 15 priority countries by 2023.
VerifiedMortality, Testing, and Prevention Interpretation
The battle against HIV reveals a story of hard-won ground, where each targeted prevention tool—from circumcision to PrEP—acts like a strategic lever slowly prying the epidemic's grip from the world's most vulnerable communities.
Prevalence and Incidence
1In 2023, approximately 39.9 million people were living with HIV globally, with 1.3 million new infections.
Verified2The global HIV incidence rate declined by 59% from 1995 to 2023.
Verified3In 2023, 630,000 people died from AIDS-related illnesses worldwide.
Verified4HIV prevalence among adults aged 15-49 was 0.8% globally in 2023.
Directional5From 2010 to 2023, new HIV infections dropped by 54% globally.
Single source6In 2022, 38.4 million people lived with HIV, including 1.3 million children.
Verified7Global AIDS-related deaths decreased by 69% since the peak in 2004.
Verified8In 2023, new HIV infections among adults were estimated at 1.3 million.
Verified9The HIV epidemic resulted in 40.4 million AIDS deaths cumulatively since 1980.
Directional10Global HIV prevalence peaked at 8.4 million new infections in 1998.
Single source11In 2023, 1.4 million adolescents aged 10-19 were living with HIV.
Verified12New HIV infections in 2023 were 30% below the 2025 target of 370,000.
Verified13Cumulative HIV infections since the epidemic began exceed 85 million.
Verified14In 2022, HIV incidence rate was 0.16% among adults 15-49.
Directional15Global new HIV infections averaged 1.5 million annually from 2010-2023.
Single source16AIDS-related deaths in 2023 numbered 630,000, down from 2.1 million in 2004.
Verified17In 2023, 39% of new HIV infections occurred in Eastern and Southern Africa.
Verified18Global HIV burden measured 39.9 million people living with HIV in 2023.
Verified19From 2010-2023, HIV incidence declined by 39% globally.
Directional20In 2023, 5.4 million people aged 50+ were living with HIV.
Single source21Global AIDS deaths peaked at 2.3 million in 2005.
Verified22New pediatric HIV infections dropped 62% from 2010 to 2023.
Verified23In 2022, 1.51 million people acquired HIV globally.
Verified24HIV prevalence among adults 15-49 was highest at 19.8% in Eswatini in 2023.
Directional25Global HIV testing reached 86% of people aged 15-49 in high-burden countries by 2023.
Single source26Cumulative AIDS deaths from 1980-2023 estimated at 42.3 million.
Verified27In 2023, HIV incidence was 1.9 per 1000 uninfected adults globally.
Verified28Global people living with HIV increased by 2.9 million from 2020 to 2023.
Verified29New HIV infections in key populations were 48% of total in 2023.
Directional30In 2023, 39.9 million [30.6–50.0 million] people lived with HIV globally.
Single sourcePrevalence and Incidence Interpretation
Though the weight of 40 million lives is still staggering, the plummeting death toll and slowing infection rate prove our battle is not a tragic fait accompli but a winnable war of attrition we are, inch by agonizing inch, beginning to turn.
Regional Statistics
1Sub-Saharan Africa accounted for 65% of global people living with HIV in 2022.
Verified2Eastern and Southern Africa had 20.8 million people living with HIV in 2023.
Verified3Western and Central Africa reported 5.1 million PLHIV in 2023.
Verified4Middle East and North Africa had 330,000 new HIV infections from 2010-2023.
Directional5Asia and Pacific region had 6.7 million PLHIV in 2023.
Single source6Latin America had 2.4 million people living with HIV in 2023.
Verified7Eastern Europe and Central Asia saw a 20% rise in new HIV infections since 2010.
Verified8Caribbean region had HIV prevalence of 1.7% among adults 15-49 in 2023.
Verified9In West Africa, Nigeria alone had 1.9 million PLHIV in 2023.
Directional10Southern Africa countries like South Africa had 7.8 million PLHIV in 2023.
Single source11Central Asia reported 190,000 PLHIV in 2023.
Verified12North Africa had under 50,000 PLHIV in 2023.
Verified13South Asia had 2.8 million PLHIV, with India at 2.5 million in 2023.
Verified14Eastern Africa saw new HIV infections drop 50% from 2010-2023.
Directional15Oceania had 64,000 PLHIV, mostly in Papua New Guinea, in 2023.
Single source16Western Europe had low HIV prevalence of 0.3% in 2023.
Verified17North America reported 1.2 million PLHIV in 2022.
Verified18Central America had 220,000 PLHIV in 2023.
Verified19In 2023, Eastern Europe had 1.9 million PLHIV.
Directional20South-East Asia had 2.1 million new infections avoided since 2010.
Single source21In 2023, 71% of PLHIV in sub-Saharan Africa knew their status.
Verified22Latin America saw 110,000 new HIV infections in 2023.
Verified23Middle East had HIV prevalence below 0.1% in most countries in 2023.
Verified24Central and South Eastern Europe had rising HIV cases due to injecting drugs.
Directional25Western and Central Africa had 190,000 AIDS deaths in 2023.
Single sourceRegional Statistics Interpretation
The grim reality is that while some regions celebrate hard-won progress, the HIV epidemic remains a devastating and disproportionate burden on Sub-Saharan Africa, holding 65% of the global caseload, yet even there, a flicker of hope persists as more people learn their status.
Treatment Access and ART Coverage
1Globally, 30.7 million PLHIV (77%) were on antiretroviral therapy in 2023.
Verified2Viral suppression among PLHIV on ART reached 72% globally in 2023.
Verified3In 2023, 25.6 million adults and 2.8 million children were on ART.
Verified4ART coverage among children lagged at 63% compared to 77% for adults.
Directional575% of PLHIV knew their HIV status in 2023 (UNAIDS 95-95-95 targets).
Single source6Low- and middle-income countries had 29.8 million on ART in 2023.
Verified7Dolutegravir-based regimens used by 75% of PLHIV on ART by 2023.
Verified8Pre-exposure prophylaxis (PrEP) users reached 1.3 million globally in 2023.
Verified9TB preventive therapy coverage among PLHIV was 47% in 2023.
Directional10In sub-Saharan Africa, ART coverage hit 82% for adults in 2023.
Single source11Differentiated service delivery models reached 20 million PLHIV by 2023.
Verified12Viral load testing availability increased to 70% of PLHIV on ART.
Verified13Long-acting ART formulations in trials for 2024 rollout.
Verified1496% of PLHIV on ART in Western Europe achieved viral suppression.
Directional15Multi-month dispensing of ART adopted in 50+ countries by 2023.
Single source16Pediatric ART formulations improved access for 2.8 million children.
Verified17Community-led ART distribution served 15% of PLHIV in 2023.
Verified18ART initiation within 7 days of diagnosis (test-and-treat) at 90% globally.
Verified198.5 million PLHIV not on ART faced treatment gap in 2023.
Directional20Viral suppression rate was 89% among those on ART in 2023.
Single source21HIV self-testing kits distributed to 100 million people by 2023.
VerifiedTreatment Access and ART Coverage Interpretation
We're closing in on the global target but must urgently find and treat the remaining millions while celebrating that the vast majority on medication are thriving.
Sources & References
- Reference 1UNAIDSunaids.orgVisit source
- Reference 2WHOwho.intVisit source
- Reference 3AIDSINFOaidsinfo.unaids.orgVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5HIVINFOhivinfo.nih.govVisit source
- Reference 6DATAdata.unicef.orgVisit source
- Reference 7KFFkff.orgVisit source
- Reference 8THELANCETthelancet.comVisit source
- Reference 9NACAnaca.gov.ngVisit source
- Reference 10NICDnicd.ac.zaVisit source
- Reference 11NACOnaco.gov.inVisit source
- Reference 12ECDCecdc.europa.euVisit source
- Reference 13EUROeuro.who.intVisit source
- Reference 14PAHOpaho.orgVisit source
- Reference 15EMROemro.who.intVisit source
- Reference 16UNICEFunicef.orgVisit source
- Reference 17LANCETlancet.comVisit source
- Reference 18UNFPAunfpa.orgVisit source
- Reference 19NIAIDniaid.nih.govVisit source
- Reference 20USAIDusaid.govVisit source
- Reference 21UNODCunodc.orgVisit source
- Reference 22FPNWOfpnwo.orgVisit source
- Reference 23PEPFARpepfar.govVisit source